Latest Breaking News On - Prnewswire index pharmaceuticals holding - Page 1 : comparemela.com

InDex Pharmaceuticals announces expected cash balance per March 31, 2024

InDex Pharmaceuticals announces expected cash balance per March 31, 2024
finanznachrichten.de - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from finanznachrichten.de Daily Mail and Mail on Sunday newspapers.

Stefan klotterJenny sundqvistJohan gilIndex pharmaceuticals holdingKindex pharmaceuticalsPrnewswire index pharmaceuticals holdingDex pharmaceuticalsInduction studyAbuse regulationNasdaq first north growth marketAddex pharmaDie performance strategieAssets sie

InDex Pharmaceuticals discontinues cobitolimod phase III program

InDex Pharmaceuticals discontinues cobitolimod phase III program
lelezard.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from lelezard.com Daily Mail and Mail on Sunday newspapers.

Jenny sundqvistJohan gilPrnewswire index pharmaceuticals holdingData monitoring committeeIndex pharmaceuticals holdingKindex pharmaceuticalsDex pharmaceuticalsInduction studyAbuse regulationNasdaq first north growth market

InDex Pharmaceuticals discontinues cobitolimod phase III program

InDex Pharmaceuticals discontinues cobitolimod phase III program
streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.

Johan gilJenny sundqvistKindex pharmaceuticalsData monitoring committeePrnewswire index pharmaceuticals holdingIndex pharmaceuticals holdingIndependent data monitoring committeeInduction studyAbuse regulationDex pharmaceuticalsNasdaq first north growth market

InDex Pharmaceuticals discontinues cobitolimod phase III program

/PRNewswire/ InDex Pharmaceuticals Holding AB (publ) ("InDex Pharmaceuticals") today announces that an independent DMC has completed the planned dose.

Johan gilJenny sundqvistData monitoring committeeKindex pharmaceuticalsPrnewswire index pharmaceuticals holdingIndex pharmaceuticals holdingIndependent data monitoring committeeInduction studyAbuse regulationDex pharmaceuticalsNasdaq first north growth market

InDex Pharmaceuticals discontinues cobitolimod phase III program

STOCKHOLM, Nov. 21, 2023 /PRNewswire/ InDex Pharmaceuticals Holding AB (publ) ("InDex Pharmaceuticals").

Johan gilJenny sundqvistKindex pharmaceuticalsData monitoring committeeIndex pharmaceuticals holdingPrnewswire index pharmaceuticals holdingInduction studyAbuse regulationDex pharmaceuticalsNasdaq first north growth market